Skip to content
Close
SEARCH
Let's Talk
Let's Talk

SOFTWARE
Discover Icon

Discover

Visualize rapid, validated insights through real-world data.
Activate Square

Activate

Streamline data preparation with guardrailed workflows.
Substantiate Square

Substantiate

Transform real-world data into decision-grade evidence.
Generate Square

Generate

Safeguard privacy and ensure utility with AI-driven technology.

SERVICES

PARTNERSHIPS

Datavant Completes Acquisition of Aetion.   Learn more → 

AdminSep 2, 2020< 1 min read

Aetion adds another $19M to its Series B to make sense of drug development and treatment data

AlleyWatch caught up with CEO Carolyn Magill to learn more about how the company powers regulators, biopharma, payers, and health technology assessment (HTA) bodies, the company’s future plans, and Aetion’s Series B, which brings the total round size to $82B extension. 

Read More
Admin

RELATED ARTICLES